Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1- pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole- 3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products

Forensic Toxicology

Volumn 30, Issue 2, 2012, Pages 114-125

  Uchiyama, Nahoko ^a   Kawamura, Maiko ^a   Kikura Hanajiri, Ruri ^a   Goda, Yukihiro ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

AM 1220; AM 1241; AM 1248; AM 2233; N (1 adamantyl) 1 pentyl 1H indazole 3 carboxamide; N (1 adamantyl) 1 pentyl 1 H indole 3 carboxamide

Indexed keywords

3 (1 NAPHTHOYL) 1 PENTYLINDOLE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; ADAMANTANE DERIVATIVE; AM 1220; AM 1248; AM 2233; AMIDE; CANNABINOID DERIVATIVE; CB 13; CRA 13; DESIGNER DRUG; ILLICIT DRUG; INDAZOLE DERIVATIVE; INDOLE; INDOLE DERIVATIVE; N (1 ADAMANTYL) 1 PENTYL 1H INDAZOLE 3 CARBOXAMIDE; N (1 ADAMANTYL) 1 PENTYL 1H INDOLE 3 CARBOXAMIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; JAPAN; LIQUID CHROMATOGRAPHY; MARKETING; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 84865779680     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-012-0136-7     Document Type: Article

References (30)

1. EMCDDA (2009) EMCDDA action on new drugs briefing paper: understanding the 'Spice' phenomenon (a report from an EMCDDA expert meeting, 6 March 2009, Lisbon). http://www.emcdda.europa.eu/attachements.cfm/att-80086-EN- Spice%20Thematic%20paper%20-%20final%20version.pdf. Accessed April 2010
2. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 57:439-441
3. Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61-66
4. Auwärter V, Dresen S, Weinmann W, Müller M, Pütz M, Ferreirós N (2009) 'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832-837
5. Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58-63
6. Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y (2010) Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 198:31-38
7. Dresen S, Ferreirós N, Pütz M, Westphal F, Zimmermann R, Auwärter V (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 45:1186-1194
8. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 29:25-37
9. Kikura-Hanajiri R, Uchiyama N, Goda Y (2011) Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Med 13:109-115
10. 2 receptors. Chem Pharm Bull 59:1203-1205
11. Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95-110
12. Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of a benzoy-lindole(2-methoxyphenyl)(1- pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol- 3-yl)-(naph-thalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitro [35S]GTPcS binding assays. Forensic Toxicol 29:132-141
13. Ernst L, Schiebel HM, Theuring C, Lindigkeit R, Beuerle T (2011) Identification and characterization of JWH-122 used as new ingredient in "Spice-like" herbal incenses. Forensic Sci Int 208:e31-e35
14. Bononi M, Belgi P, Tateo F (2011) Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203. J Anal Toxicol 35:360-363
15. EMCDDA (2011) EMCDDA-Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA EMC-DDA-Europol, Lisbon, May 2011. http://www.emcdda.europa.eu/attachements.cfm/att-132857-EN-EMCDDA- Europol%20Annual%20Report%202010A.pdf. Accessed Dec 2011
16. United Nations Office on Drugs and Crime (UNODC) (2011) Synthetic Cannabinoids in Herbal Products. April 2011. http://www.unodc.org/documents/ scientific/Synthetic-Cannabinoids.pdf. Accessed May 2011
17. EMCDDA (2011) Online sales of new psychoactive substances/'legal highs': summary of results from the 2011 multilingual snapshots., Lisbon, November 2011. http://www.emcdda.europa.eu/attachements.cfm/att-143801-EN-SnapshotSummary.pdf. Accessed Nov 2011
18. Nakajima J, Takahashi M, Seto T, Yoshida M, Kanai C, Suzuki J, Hamano T (2012) Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pente-nyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated "herbal" products circulated in the Tokyo area. Forensic Toxicol 30:33-44
19. Jankovics P, Váradi A, Tölgyesi L, Lohner S, Németh-Palotás J, Balla J (2012) Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary. Forensic Sci Int 214:27-32
20. Kneisel S, Westphal F, Moosmann B, Brecht V, Bisel P, Vidal C, Jacobsen-Bauer A, Bork WR, Auwärter V (2011) Cannabimi-metics II: mass spectra and ATR-IR spectra of new compounds between the end of 2010 and late 2011. TIAFT Bull 41:29-38
21. Grigoryev A, Kavanagh P, Melnik A (2011) The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylin-dole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test Anal. doi:10.1002/dta.350
22. Huffman JW (2009) Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. In: Reggio PH (ed) The cannabinoid receptors. Humana Press, New York, pp 49-94
23. Makriyannis A, Lui Q (2003) Patent: WO/2003/035005 May, 2003. Heteroindanes: a new class of potent cannabimimetic ligands
24. Bingham B, Jones PG, Uveges AJ, Kotnis S, Lu P, Smith VA, Sun SC, Resnick L, Chlenov M, He Y, Strassle BW, Cummons TA, Piesla MJ, Harrison JE, Whiteside GT, Kennedy JD (2007) Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol 151:1061-1070 (Pubitemid 47195523)
25. Makriyannis A, Deng H (2002) Patent: WO/2002/060447, August 2002. Receptor selective cannabimimetic aminoalkylindoles
26. Willis PG, Pavlova OA, Chefer SI, Vaupel DB, Mukhin AG, Horti AG (2005) Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography. J Med Chem 48:5813-5822 (Pubitemid 41298353)
27. Deng H, Gifford AN, Zvonok AM, Cui G, Li X, Fan P, Deschamps JR, Flippen-Anderson JL, Gatley SJ, Makriyannis A (2005) Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor. J Med Chem 48:6386-6392 (Pubitemid 41428990)
28. 9-tetrahydrocannabinol) discrimination for rats. Behav Pharmacol 22:498-507
29. Dziadulewicz EK, Bevan SJ, Brain CT, Coote PR, Culshaw AJ, Davis AJ, Edwards LJ, Fisher AJ, Fox AJ, Gentry C, Groarke A, Hart TW, Huber W, James IF, Kesingland A, La Vecchia L, Loong Y, Lyothier I, McNair K, O'Farrell C, Peacock M, Port-mann R, Schopfer U, Yaqoob M, Zadrobilek J (2007) Naphtha-len-1-yl-(4- pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J Med Chem 50:3851-3856 (Pubitemid 47292048)
30. Liu J, Obando D, Liao V, Lifa T, Codd R (2011) The many faces of the adamantyl group in drug design. Eur J Med Chem 46:1949-1963